A federal judge has certified a class action antitrust suit against pharmaceuticals giant GlaxoSmithKline that accuses the company of using a series of illegal tactics to delay the approval of generic ...
GSK plc (NYSE: GSK) on Tuesday agreed to acquire RAPT Therapeutics Inc. (NASDAQ: RAPT) for $58.00 per share. The deal consideration is equivalent to an estimated aggregate equity value of $2.2 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results